People with shorter protective caps at the end of their chromosomes (called telomeres) may be more likely to develop ...

Shorter telomeres are linked to higher risks of stroke, dementia, and depression, but lifestyle factors may help counteract ...

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people. A new study, however, suggests that it may now be easier to predict who is ...

A COVID-19 diagnosis is no longer as frightening as it used to be, thanks to developments in treatment choices. However, a ...

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people. A new study, however, suggests that it may now be easier to predict who is ...

Higher levels of leukocytes -- a form of white blood cell -- are associated with more severe symptoms of long COVID among ...

Leukocyte count was linked to the severity of post-acute sequelae of SARS-CoV-2 infection but not of PASC occurrence or ...

A new study suggests that a simple blood test measuring leukocyte levels, a type of white blood cell, might predict the ...

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people.

Leukocyte count, a widely available and inexpensive clinical marker of inflammation, may help predict the severity of long COVID symptoms in postmenopausal women, researchers reported.

Pluristyx has developed a clinical-grade manufacturing process for using a licensed Mad7 gene editing technology to block Human Leukocyte Antigen (HLA) markers expression. Humacyte is optimizing a ...